Sigma Healthcare Inkomsten in het verleden

Verleden criteriumcontroles 0/6

De winst van Sigma Healthcare is gedaald met een gemiddeld jaarlijks percentage van -10.1%, terwijl de winst van de Healthcare -industrie jaarlijks daalde met 3.3%. De inkomsten zijn groeide met een gemiddeld percentage van 0.5% per jaar.

Belangrijke informatie

-10.1%

Groei van de winst

-11.9%

Groei van de winst per aandeel

Healthcare Groei van de industrie	2.4%
Inkomstengroei	0.5%
Rendement op eigen vermogen	-0.2%
Nettomarge	-0.09%
Laatste winstupdate	31 Jul 2024

Recente prestatie-updates uit het verleden

Recent updates

Sigma Healthcare Limited's (ASX:SIG) Subdued P/S Might Signal An Opportunity

Feb 24

Is There An Opportunity With Sigma Healthcare Limited's (ASX:SIG) 49% Undervaluation?

Jan 05

Sigma Healthcare (ASX:SIG) Will Pay A Dividend Of AU$0.01

Mar 31

Some Investors May Be Worried About Sigma Healthcare's (ASX:SIG) Returns On Capital

Dec 08

The Returns On Capital At Sigma Healthcare (ASX:SIG) Don't Inspire Confidence

May 11

Shareholders Shouldn’t Be Too Comfortable With Sigma Healthcare's (ASX:SIG) Strong Earnings

Mar 29

Sigma Healthcare Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Mar 24

How Many Sigma Healthcare Limited (ASX:SIG) Shares Do Institutions Own?

Feb 16

We Think Sigma Healthcare (ASX:SIG) Has A Fair Chunk Of Debt

Jan 19

What Type Of Returns Would Sigma Healthcare's(ASX:SIG) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

Dec 31

Are Insiders Buying Sigma Healthcare Limited (ASX:SIG) Stock?

Dec 13

Opbrengsten en kosten

Hoe Sigma Healthcare geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

ASX:SIG Opbrengsten, kosten en inkomsten (AUD Millions )
Datum	Inkomsten	Inkomsten	G+A Uitgaven
31 Jul 24	3,481	-3	267
30 Apr 24	3,401	1	260
31 Jan 24	3,322	5	254
31 Oct 23	3,414	10	263
31 Jul 23	3,506	15	271
30 Apr 23	3,583	8	282
31 Jan 23	3,660	2	293
31 Oct 22	3,605	-3	300
31 Jul 22	3,550	-7	308
30 Apr 22	3,498	-7	309
31 Jan 22	3,446	-7	310
31 Oct 21	3,469	20	304
31 Jul 21	3,491	47	298
30 Apr 21	3,446	45	303
31 Jan 21	3,400	44	309
31 Oct 20	3,205	12	306
31 Jul 20	3,009	-19	302
30 Apr 20	3,127	-16	296
31 Jan 20	3,244	-12	289
31 Oct 19	3,570	7	290
31 Jul 19	3,897	26	292
30 Apr 19	3,937	31	294
31 Jan 19	3,977	37	296
31 Oct 18	4,015	39	295
31 Jul 18	4,054	41	293
30 Apr 18	4,074	48	284
31 Jan 18	4,094	55	275
31 Oct 17	4,156	56	269
31 Jul 17	4,218	57	264
30 Apr 17	4,292	55	261
31 Jan 17	4,366	53	258
31 Oct 16	4,149	54	254
31 Jul 16	3,932	55	251
30 Apr 16	3,697	53	244
31 Jan 16	3,461	51	236
31 Oct 15	3,388	50	227
31 Jul 15	3,315	49	219
30 Apr 15	3,229	51	210
31 Jan 15	3,142	53	201
31 Oct 14	3,077	56	192
31 Jul 14	3,012	60	182
30 Apr 14	2,993	57	181
31 Jan 14	2,973	54	180

Kwaliteitswinsten: SIG is momenteel verliesgevend.

Groeiende winstmarge: SIG is momenteel verliesgevend.

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: SIG is verliesgevend en de verliezen zijn de afgelopen 5 jaar toegenomen met een snelheid van 10.1% per jaar.

Versnelling van de groei: Het is niet mogelijk om de winstgroei van SIG over het afgelopen jaar te vergelijken met het gemiddelde over de afgelopen vijf jaar, omdat het bedrijf momenteel verliesgevend is.

Winst versus industrie: SIG is verlieslatend, waardoor het lastig is om de winstgroei van het afgelopen jaar te vergelijken met die van de Healthcare industrie ( -25.4% ).

Rendement op eigen vermogen

Hoge ROE: SIG heeft een negatief Return on Equity ( -0.25% ), omdat het momenteel verliesgevend is.

Sigma Healthcare Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Belangrijke informatie

Recente prestatie-updates uit het verleden

First half 2025 earnings released: EPS: AU$0.002 (vs AU$0.011 in 1H 2024)

Sigma Healthcare Limited to Report Q2, 2025 Results on Sep 25, 2024

Sigma Healthcare Limited to Report Fiscal Year 2024 Results on Mar 21, 2024

Sigma Healthcare Limited to Report First Half, 2024 Results on Sep 20, 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.001 loss in 1H 2022)

Recent updates

First half 2025 earnings released: EPS: AU$0.002 (vs AU$0.011 in 1H 2024)

First half dividend of AU$0.005 announced

Price target increased by 7.3% to AU$1.24

Sigma Healthcare Limited to Report Q2, 2025 Results on Sep 25, 2024

New minor risk - Earnings quality

Consensus EPS estimates fall by 16%

First half dividend of AU$0.005 announced

Price target increased by 9.8% to AU$0.98

Sigma Healthcare Limited to Report Fiscal Year 2024 Results on Mar 21, 2024

Consensus EPS estimates increase by 29%

Price target increased by 9.9% to AU$0.94

Sigma Healthcare Limited's (ASX:SIG) Subdued P/S Might Signal An Opportunity

New major risk - Shareholder dilution

Is There An Opportunity With Sigma Healthcare Limited's (ASX:SIG) 49% Undervaluation?

New minor risk - Shareholder dilution

Sigma Healthcare Limited has filed a Follow-on Equity Offering.

Sigma Healthcare Limited has filed a Follow-on Equity Offering.

Sigma Healthcare Limited has filed a Follow-on Equity Offering.

Sigma Healthcare Limited, Annual General Meeting, May 30, 2024

Less than half of directors are independent

Sigma Healthcare Limited Announces Christopher Graham Roberts as Director

Consensus EPS estimates fall by 24%

Sigma Healthcare Limited Declares Fully Franked Dividend for the Six Month Ended July 31, 2023, Payable on October 11, 2023

Sigma Healthcare Limited to Report First Half, 2024 Results on Sep 20, 2023

Sigma Healthcare Limited Appoints Mark Conway as CFO, Effective from 1 November 2023

Sigma Healthcare Limited Announces Executive Changes

Price target increased by 21% to AU$0.69

Less than half of directors are independent

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Sigma Healthcare Limited Announces Board Changes

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.001 loss in 1H 2022)

Sigma Healthcare Limited Declares Interim Fully Franked Dividend, Payable on 12 October 2022

Sigma Healthcare Limited Announces Executive Changes

Sigma Healthcare Limited Appoints Nigel Simonsz as Chief Financial Officer, Effective 29 August 2022

Sigma Healthcare Limited Appoints Nigel Simonsz as Chief Financial Officer, Effective 29 August 2022

Independent Non-Executive Director recently bought AU$56k worth of stock

Sigma Healthcare Limited Announces Appointment of Josephine De Martino as Interim Chief Financial Officer

Sigma Healthcare Limited, Annual General Meeting, May 10, 2023

Sigma Healthcare (ASX:SIG) Will Pay A Dividend Of AU$0.01

Full year 2022 earnings: Revenues in line with analyst expectations

Sigma Healthcare Limited Provides Earnings Guidance for the Year 2023

Consensus estimates of losses per share improve by 36%

Consensus EPS estimates fall by 22%

Some Investors May Be Worried About Sigma Healthcare's (ASX:SIG) Returns On Capital

Price target decreased to AU$0.60

Consensus EPS estimates fall to -AU$0.011

Simon Mawhinney Opposes Sigma Healthcare’s Bid to Australian Pharmaceutical

First half 2022 earnings released: AU$0.001 loss per share (vs AU$0.004 loss in 1H 2021)

Independent Non-Executive Director has left the company

The Returns On Capital At Sigma Healthcare (ASX:SIG) Don't Inspire Confidence

Upcoming dividend of AU$0.01 per share

Shareholders Shouldn’t Be Too Comfortable With Sigma Healthcare's (ASX:SIG) Strong Earnings

Sigma Healthcare Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Full year 2021 earnings released: EPS AU$0.061 (vs AU$0.013 loss in FY 2020)

How Many Sigma Healthcare Limited (ASX:SIG) Shares Do Institutions Own?

New 90-day high: AU$0.73

New 90-day high: AU$0.63

We Think Sigma Healthcare (ASX:SIG) Has A Fair Chunk Of Debt

What Type Of Returns Would Sigma Healthcare's(ASX:SIG) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

New 90-day high: AU$0.61

Are Insiders Buying Sigma Healthcare Limited (ASX:SIG) Stock?

CEO, MD & Executive Director recently bought AU$135k worth of stock

New 90-day low: AU$0.56

Sigma Healthcare Appoints Jackie Pearson as Chief Financial Officer

CEO, MD & Executive Director recently bought AU$296k worth of stock

New 90-day low: AU$0.58

First half earnings released

Sigma Healthcare Limited Announces No Interim Dividend for the Half Year Ended 31 July 2020

Price target raised to AU$0.69